Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche

Pancreatic cancer is a deadly disease with high rates of metastasis, though how tumor cells establish metastatic lesions is not fully understood. A key feature of primary pancreatic tumors is extensive fibrosis due to deposition of extracellular matrix. While pancreatic cancer cells are programmed by stimuli derived from a stiff ECM, metastasis requires loss of attachment as well as adaptation to a softer microenvironment upon reaching distant sites. Growing evidence suggests that stiff ECM influences pancreatic cancer cell behaviour. Here we argue that this influence is reversible and that pancreatic cancer cells can be reprogrammed upon sensing of soft substrates. Through use of engineered polyacrylamide hydrogels with tuneable mechanical properties, we show that Collagen-VI is specifically upregulated on soft substrates, due to a lack of integrin engagement and low YAP1 activity. Collagen-VI supports migration in vitro and metastasis formation in vivo. Metastatic nodules formed by pancreatic cancer cells lacking Col6a1 expression, were characterised by stromal cell-derived collagen-VI deposition, suggesting that collagen-VI, either cancer or stroma derived, is an essential component of the metastatic niche. Summary Statement Collagen-VI is expressed by pancreatic tumors and metastases in a mechanosensitive way to promote niche colonisation.

[1]  Paul Theodor Pyl,et al.  Analysing high-throughput sequencing data in Python with HTSeq 2.0 , 2021, Bioinform..

[2]  J. Yeh,et al.  The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies , 2021, Frontiers in Oncology.

[3]  E. Fertig,et al.  A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy , 2021, Nature Cancer.

[4]  R. Schwabe,et al.  Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. , 2021, The Journal of clinical investigation.

[5]  A. Rao,et al.  Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer , 2021, Cell reports.

[6]  L. Machesky,et al.  The liver metastatic niche: modelling the extracellular matrix in metastasis , 2021, Disease models & mechanisms.

[7]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[8]  S. Naber,et al.  Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis , 2020, Science Advances.

[9]  Keith E. Volmar,et al.  Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. , 2020, The Journal of clinical investigation.

[10]  D. Tuveson,et al.  Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma , 2020, Cancer Research.

[11]  M. Salmerón-Sánchez,et al.  The creatine–phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis , 2020, Nature Metabolism.

[12]  Yvette W. H. Koh,et al.  N-WASP Control of LPAR1 Trafficking Establishes Response to Self-Generated LPA Gradients to Promote Pancreatic Cancer Cell Metastasis , 2019, Developmental cell.

[13]  S. Carr,et al.  Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells , 2019, Proceedings of the National Academy of Sciences.

[14]  P. Robson,et al.  Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. , 2019, Cancer discovery.

[15]  S. Piccolo,et al.  YAP and TAZ: a signalling hub of the tumour microenvironment , 2019, Nature Reviews Cancer.

[16]  M. Salmerón-Sánchez,et al.  Tissue engineering the cancer microenvironment—challenges and opportunities , 2018, Biophysical Reviews.

[17]  E. Farge,et al.  Mechanotransduction in tumor progression: The dark side of the force , 2018, The Journal of cell biology.

[18]  M. Tempero,et al.  HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer. , 2018, Future oncology.

[19]  S. Piccolo,et al.  Mechanobiology of YAP and TAZ in physiology and disease , 2017, Nature Reviews Molecular Cell Biology.

[20]  N. Yang,et al.  VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer , 2017, Scientific Reports.

[21]  S. Karim,et al.  Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells , 2017, Oncogenesis.

[22]  P. Mangu,et al.  Locally Advanced Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. , 2017, Journal of oncology practice.

[23]  Christine A Iacobuzio-Donahue,et al.  Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression , 2016, Nature Medicine.

[24]  Randy L. Johnson,et al.  Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. , 2015, Cell reports.

[25]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[26]  Ben S. Wittner,et al.  Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells , 2014, Cell reports.

[27]  I. Petrache,et al.  Overexpression of type VI collagen in neoplastic lung tissues , 2014, Oncology reports.

[28]  Umar Mahmood,et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.

[29]  G. Alves,et al.  Pathology and Genetics , 1998 .

[30]  P. Bonaldo,et al.  Collagen VI in cancer and its biological mechanisms. , 2013, Trends in molecular medicine.

[31]  Matthew E. Berginski,et al.  The Focal Adhesion Analysis Server: a web tool for analyzing focal adhesion dynamics , 2013, F1000Research.

[32]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[33]  P. Scherer,et al.  Adipocyte-derived endotrophin promotes malignant tumor progression. , 2012, The Journal of clinical investigation.

[34]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[35]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[36]  L. Machesky,et al.  Cells Assemble Invadopodia-Like Structures and Invade into Matrigel in a Matrix Metalloprotease Dependent Manner in the Circular Invasion Assay , 2012, PloS one.

[37]  Steven A. Carr,et al.  The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices , 2011, Molecular & Cellular Proteomics.

[38]  Shawn M. Gomez,et al.  High-Resolution Quantification of Focal Adhesion Spatiotemporal Dynamics in Living Cells , 2011, PloS one.

[39]  Paul Timpson,et al.  Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.

[40]  S. Yachida,et al.  The pathology and genetics of metastatic pancreatic cancer. , 2009, Archives of pathology & laboratory medicine.

[41]  Valerie M. Weaver,et al.  A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.

[42]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[43]  D. V. Von Hoff,et al.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma , 2007, Molecular Cancer Therapeutics.

[44]  Anna Huttenlocher,et al.  Talin1 Regulates TCR-Mediated LFA-1 Function1 , 2006, The Journal of Immunology.

[45]  Brett L. Kutscher,et al.  A Conformational Switch in Vinculin Drives Formation and Dynamics of a Talin-Vinculin Complex at Focal Adhesions* , 2006, Journal of Biological Chemistry.

[46]  E. Petricoin,et al.  Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. , 2005, The Journal of clinical investigation.

[47]  S. Dedhar,et al.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK , 2005, Nature Reviews Cancer.

[48]  Donna J. Webb,et al.  FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly , 2004, Nature Cell Biology.

[49]  Donald R Schwartz,et al.  Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. , 2003, Cancer cell.

[50]  D. Webb,et al.  Differential Dynamics of α5 Integrin, Paxillin, and α-Actinin during Formation and Disassembly of Adhesions in Migrating Cells , 2001, The Journal of cell biology.